Platelet paroxetine binding in post-traumatic stress disorder

Abstract

Sixty-two subjects, 45 with post-traumatic stress disorder (PTSD) and 17 healthy control subjects, were examined in a study of serotonin function measured by [ 3H]paroxetine binding to platelet membranes. Subjects were selected from male combat exposed veterans. The mean (±S.D.) K d was 0.078 ± 0.045 nM for the PTSD patient group and 0.064 ± 0.037 nM for the control group. The mean B max was 934 ± 238 fmol/mg protein for the PTSD patient group and 1011 ± 363 fmol/mg protein for the control group. There was no significant difference between the groups for either K d or B max, before or after controlling for season of sampling. There were no significant differences between subjects with current PTSD and those with PTSD in the past, or between PTSD subjects with or without concurrent major depressive disorder. This study finds no relationship between PTSD, major depressive disorder and peripheral serotonin function measured by [ 3H]paroxetine binding to blood platelets.